The path to restful nights

Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA). Nyxoah's lead solution platform is based on the Genio® system, a validated, patient-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Discover Genio®
genio applied

Major Shareholders

Press Releases

More news

Nyxoah Issues First Quarter 2021 Results

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

Nyxoah BETTER SLEEP Trial Reaches its Primary Endpoints

bubble
bubble
bubble
bubble
bubble